Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Free Report) – Equities researchers at Seaport Res Ptn cut their Q2 2024 earnings per share (EPS) estimates for shares of Curaleaf in a report issued on Tuesday, July 23rd. Seaport Res Ptn analyst S. Randhawa now anticipates that the company will post earnings of ($0.07) per share for the quarter, down from their previous forecast of ($0.06). The consensus estimate for Curaleaf’s current full-year earnings is ($0.21) per share. Seaport Res Ptn also issued estimates for Curaleaf’s Q3 2024 earnings at ($0.06) EPS, Q4 2024 earnings at ($0.06) EPS, FY2024 earnings at ($0.26) EPS, Q1 2025 earnings at ($0.05) EPS, Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.04) EPS and Q4 2025 earnings at ($0.03) EPS.
Separately, Needham & Company LLC upped their target price on shares of Curaleaf from $5.25 to $6.25 and gave the company a “buy” rating in a research note on Friday, May 10th.
Curaleaf Price Performance
Shares of OTCMKTS:CURLF opened at $4.03 on Friday. The firm has a market capitalization of $2.61 billion, a PE ratio of -10.33 and a beta of 0.88. The company has a current ratio of 0.72, a quick ratio of 0.36 and a debt-to-equity ratio of 0.74. Curaleaf has a 1-year low of $2.51 and a 1-year high of $6.40. The business’s 50 day moving average is $4.27 and its 200-day moving average is $4.80.
Curaleaf (OTCMKTS:CURLF – Get Free Report) last posted its quarterly earnings data on Thursday, May 9th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by ($0.01). The company had revenue of $338.93 million for the quarter, compared to the consensus estimate of $341.25 million. Curaleaf had a negative return on equity of 14.43% and a negative net margin of 20.29%.
Curaleaf Company Profile
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
See Also
- Five stocks we like better than Curaleaf
- What Makes a Stock a Good Dividend Stock?
- Why Call Options Volume for These 2 Stocks Spiked Together
- How is Compound Interest Calculated?
- MarketBeat Week in Review – 7/22 – 7/26
- How to Most Effectively Use the MarketBeat Earnings Screener
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.